Sinovac says its Covid-19 vaccine more effective with longer dosing interval


A health worker shows the Sinovac vaccine against the Covid-19 coronavirus at a community health centre in Lambaro, Indonesia's Aceh province on Monday (Jan 18, 2021). - AFP

BEIJING, Jan 18 (Reuters): China's Sinovac Biotech said on Monday that a clinical trial in Brazil showed its Covid-19 vaccine was almost 20 percentage points more effective in a small sub-group of patients who received their two doses longer apart.

The protection rate for 1,394 participants who received doses of either CoronaVac or placebo three weeks apart was nearly 70%, a Sinovac spokesman said.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
   

Next In Aseanplus News

Cambodia launches mobile app to combat violence against women, girls
Lao govt seeks measures to address challenges for next year
Brunei-born star Wu Chun opens up about 20 years of insomnia: ‘I sleep less than 6 hours a night’
Indonesia calls Apple’s US$100mil investment offer unfair and inadequate
Philippine VP Duterte labelled 'mastermind' of assassination plot
Malaysia's political crossroads: Navigating challenges post-GE15
Cricket-Pacer Bhuvneshwar joins Bengaluru for $1.28 million in IPL auction
Next round of talks for Asean – India trade pact slated for February next year
Elderly man from India allegedly molested four women on board Singapore Airlines flight
TotalEnergies pauses funding for Adani Group after bribery charges

Others Also Read